Your browser doesn't support javascript.
loading
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease.
Saketkoo, Lesley Ann; Escorpizo, Reuben; Varga, Janos; Keen, Kevin John; Fligelstone, Kim; Birring, Surinder S; Alexanderson, Helene; Pettersson, Henrik; Chaudhry, Humza Ahmad; Poole, Janet L; Regardt, Malin; LeSage, Daphne; Sarver, Catherine; Lanario, Joseph; Renzoni, Elisabetta; Scholand, Mary Beth; Lammi, Matthew R; Kowal-Bielecka, Otylia; Distler, Oliver; Frech, Tracy; Shapiro, Lee; Varju, Cecilia; Volkmann, Elizabeth R; Bernstein, Elana J; Drent, Marjolein; Obi, Ogugua Ndili; Patterson, Karen C; Russell, Anne-Marie.
Afiliação
  • Saketkoo LA; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, United States.
  • Escorpizo R; University Medical Center-Comprehensive Pulmonary Hypertension Center & Interstitial Lung Disease Clinic Programs, New Orleans, LA, United States.
  • Varga J; Tulane University School of Medicine, New Orleans, LA, United States.
  • Keen KJ; Louisiana State University Health Sciences Center, Division of Pulmonary Medicine-New Orleans, New Orleans, LA, United States.
  • Fligelstone K; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, VT, United States.
  • Birring SS; Swiss Paraplegic Research, Nottwil, Switzerland.
  • Alexanderson H; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Pettersson H; Department of Mathematics and Statistics and Health Research Institute, University of Northern British Columbia, Prince George, BC, Canada.
  • Chaudhry HA; Department of Medicine, University of British Columbia & Centre for Heart Lung Innovation, Providence Research, Vancouver, BC, Canada.
  • Poole JL; Patient Research Partner Scleroderma & Raynaud Society, UK (SRUK) and Federation of European Scleroderma Associations, London, United Kingdom.
  • Regardt M; Royal Free Hospital Scleroderma Unit, London, United Kingdom.
  • LeSage D; Division of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom.
  • Sarver C; Women's Health and Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
  • Lanario J; Department of Medicin, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
  • Renzoni E; Women's Health and Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
  • Scholand MB; Department of Medicin, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
  • Lammi MR; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, United States.
  • Kowal-Bielecka O; University Medical Center-Comprehensive Pulmonary Hypertension Center & Interstitial Lung Disease Clinic Programs, New Orleans, LA, United States.
  • Distler O; Tulane University School of Medicine, New Orleans, LA, United States.
  • Frech T; Occupational Therapy Graduate Program, University of New Mexico, Albuquerque, NM, United States.
  • Shapiro L; Women's Health and Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
  • Varju C; Department of Medicin, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
  • Volkmann ER; Patient Research Partner, New Orleans, LA, United States.
  • Bernstein EJ; Patient Research Partner, Baltimore, MD, United States.
  • Drent M; Research Fellow in Respiratory Health-Exeter Respiratory Institute Royal Devon University Hospitals NHS Foundation Trust, Exeter, United Kingdom.
  • Obi ON; Royal Brompton Hospital, National Heart and Lung Institute, London, United Kingdom.
  • Patterson KC; Pulmonary Medicine, University of Utah, Salt Lake City, UT, United States.
  • Russell AM; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, United States.
Front Pharmacol ; 13: 979788, 2022.
Article em En | MEDLINE | ID: mdl-36313333
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article